Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
NCT07695259
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Elderly Females
HER2 + Breast Cancer
Neoadjuvant Therapy
Interventions
DRUG:
olaparib combined with trastuzumab and pertuzumab
Sponsor
Wen-Ming Cao